Maple Leaf Green World

Corporate Overview

Maple Leaf Green World Inc (NEO:MGW & OTCQB:MGWFF) and its subsidiaries (“Maple Leaf”) focus on the emerging cannabis industry in North America. Maple Leaf leverages a decade of extensive greenhouse management experience, eco-agricultural knowledge, and cultivation technology with the goal of producing high quality cannabis products for both the domestic and international market.

Maple Leaf has land holdings in British Columbia, Nevada, and California allowing it to be uniquely positioned in the North American market. The company has filed an application under Access to Cannabis Medical Purposes Regulations (ACMPR) for its cultivation project in British Columbia and is currently under Active Review – Stage 5 of 7 established under the ACMPR. Maple Leaf owns a Medical Marijuana Establishment Cultivation Permit in Nevada and is in the process of constructing a 20,000 sq. ft. indoor cultivation facility in Henderson, Nevada. Maple Leaf is also in the process of constructing a 27,200 sq. ft. indoor cultivation facility in British Columbia. The company owns two 3,000 sq. ft. greenhouse facilities in California and is anticipating the construction of an additional ten greenhouses. Additionally, the company has plans to develop cannabis-derived oil products for export to global markets with medical cannabis programs in place.

Company Highlights

• Over ten years of eco-agricultural experience.
• Targeting combined annual production capacity of 10,000 kilograms of top quality cannabis in North America.
• Focused on developing new strains with high cannabidiol levels.
• Produce top quality cannabis for the production of medical-grade cannabis-derived oil.
• Have built two 3,000 sq. ft. greenhouse facilities in California on 20 acres of company owned land.
• Permitted for 20,000 with a potential expansion of an additional 33,500 sq. ft. facility in Henderson, 15 miles from Las Vegas, Nevada.
• 27,200 sq. ft. indoor cultivation facility under construction in Telkwa BC, stated for completion by end of 2018.
• Facilities strategically chosen to promptly respond to both the medical and recreational sectors of cannabis in both Canada and the U.S.